Your Article Summary
See Latest ArticlesCytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Bone Marrow Transplantation, 07/01/09
Mattsson J et al. - Positive T- and/or B-crossmatch before SCT had no predictive value for survival in this study as compared with patients with a negative crossmatch. The pretransplant cytotoxic T- and/or B-crossmatch is a poor predictor of rejection after allo-SCT.
Related Articles
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, 10/07/09
Relevance Score: 88%
Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
Bone Marrow Transplantation, 11/05/09
Relevance Score: 87%
Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09
Relevance Score: 87%
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
Bone Marrow Transplantation, 10/07/09
Relevance Score: 87%
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
British Journal of Haematology, 10/06/09
Relevance Score: 87%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation
Experimental Hematology, 12/15/09
Granulocyte Colony-Stimulating Factor Increases the Platelet Volume in Peripheral Stem Cell Apheresis Donors
Pathophysiology of Haemostasis and Thrombosis, 12/14/09
Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Haematologica, 12/14/09